Study Evaluating Telemonitoring and Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAPES Program) Compared to Standard of Care in Patients With Chronic Respiratory Failure Receiving Non-invasive Home Ventilation
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)Obesity Hypoventilation Syndrome (OHS)Chronic Respiratory Failure With Hypercapnia
- Interventions
- Device: ETAPES Program
- Registration Number
- NCT04615078
- Lead Sponsor
- Air Liquide Santé International
- Brief Summary
The ETAPES Program, a French national Experimentation in Telemedicine for the Improvement of Healthcare Pathways, was launched in 2018 for 4 years. Its objectives were to provide a temporary public reimbursement for medical telemonitoring in order to determine the benefits for the patient and the impact on medical organization and healthcare costs. In particular, this program applies to patients suffering from hypercapnic chronic respiratory failure and requiring home non invasive ventilation (NIV). For these patients, the ETAPES program combines NIV telemonitoring and therapeutic education.
e-VENT study aims at evaluating the ETAPES program, implemented using the Chronic Care Connect™ telemonitoring solution, versus Standard of Care, on the effectiveness of home NIV, measured by average PtCO2, reflecting the level of nocturnal alveolar hypoventilation.
- Detailed Description
A prospective randomized study with two arms.
The primary endpoint is the level of nocturnal alveolar hypoventilation, defined as the average PtCO2 in nocturnal capnography performed at 6th month.
Patients with hypercapnic chronic respiratory failure requiring home NIV (n=100).
Multi-center study conducted in France involving approximately 20 sites
Product under study: Chronic Care Connect Pneumology telemonitoring solution, combining:
* a technical solution for the transmission and analysis of ventilator data, with the generation of alerts by a CE-marked algorithm;
* an organizational solution relying on a nurse call center.
Study design:
* First visit: eligibility criteria confirmation; randomization to 2 groups:
* the "Telemonitoring" group will participate in the ETAPES experimentation, with remote monitoring of their ventilator data with generation of alerts to the nurse call center, medical action if requested, and therapeutic education.
* the "Standard of Care" group will receive standard medical follow-up, with transmission of their ventilator data without generation of alerts.
* Second visit (6th month): arterial blood gases, nocturnal capnography. Collection of medical events having occurred in the past 6 months.
* Third visit (12th month): for COPD patients only - Collection of medical events having occurred in the past 6 months.
* At the end of the study, the investigators will complete a qualitative questionnaire on their telemonitoring practice.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
-
Patient with chronic respiratory failure for whom treatment with home NIV was prescribed at inclusion or two months earlier, and whose service provider is ADEP Assistance, ADAIR Assistance, ARAIR Assistance or VitalAire,
-
Patient who meets all eligibility criteria to participate in the ETAPES program, namely:
- Patient aged 18 and over;
- Patient receiving NIV as part of an indication recognized by the Société de Pneumologie de Langue Française and the Haute Autorité de Santé;
-
Patient never before included in the ETAPES program for the remote medical monitoring of their chronic respiratory failure;
-
Patient having agreed to participate in the ETAPES program with the Chronic Care Connect Pneumology solution operated by the service providers ADEP Assistance, ADAIR Assistance, ARAIR Assistance or VitalAire, in the event that they are randomized to the Remote Medical Monitoring group;
-
Patient agreeing to the collection of data from their ventilator via remote transmission;
-
Patient fitted with a ventilator compatible with the Chronic Care Connect Pneumology solution;
-
Patient with health insurance cover;
-
Patient who has signed the consent form for the study.
-
Patient who has any of the non-eligibility criteria for the ETAPES program:
- Physical or mental inability to use all components of the remote medical monitoring project, as determined by the doctor wishing to include the patient in the remote medical monitoring project;
- Patient with cancer with a life expectancy of less than 12 months estimated by the pulmonologist;
- Patient with more than three COPD respiratory decompensations resulting in hospitalization within the previous 12 months;
- Patient with diagnosed neuromuscular disease;
- Estimated poor compliance or standard adherence to treatment according to the physician including the patient;
- Patient's refusal of treatment support;
- No permanent place of residence;
-
Patient participating in another intervention research program.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description "Telemonitoring" group ETAPES Program Medical Telemonitoring in Non-Invasive Ventilation
- Primary Outcome Measures
Name Time Method Nocturnal alveolar hypoventilation data 6th month Average PtCO2, measured by transcutaneous capnography
- Secondary Outcome Measures
Name Time Method Number of medical events (consultations, hospitalizations and COPD exacerbations) related to Chronic Respiratory Failure 6th month; 12th month Average number of medical events (consultations, hospitalizations and COPD exacerbations) related to Chronic Respiratory Failure per patient
Quality of NIV treatment Through study completion, an average estimated at around 7 months Daily data teletransmitted by ventilators throughout the follow-up period
Measurement of diurnal PaO2 and PaCO2 6th month Measurement of diurnal PaO2 and PaCO2 (mmHg) without NIV, in stable state at rest
S3-NIV questionnaire Through study completion, an average estimated at around 7 months Questionnaire evaluating sleep, side effects and symptoms in patients on home NIV, each time the service provider visits the patient at home
DIRECT questionnaire 1st month; 6th month Total health-related quality-of-life score from the DIRECT questionnaire as recommended in the ETAPES program, submitted to the patients in the month following their inclusion and in the 6th month
Patient satisfaction questionnaire about Telemonitoring services 6th month Questionnaire developed for the study to collect patient satisfaction about the educational component of the telemonitoring service at the end of their participation to the study
Trial Locations
- Locations (11)
Clinique FSEF Paris 16ème
🇫🇷Paris, France
Centre Hospitalier de Boulogne sur Mer
🇫🇷Boulogne-sur-Mer, France
Centre Hospitalier de Bligny
🇫🇷Briis-sous-Forges, France
Claude SCHMITZ, MD
🇫🇷Colmar, France
François BUGHIN, MD - Clinique du Millénaire
🇫🇷Montpellier, France
Hôpital Forcilles - Fondation Cognacq-Jay
🇫🇷Férolles-Attilly, France
Groupe Hospitalier Pitié Salpêtrière-Charles Foix
🇫🇷Paris, France
Groupe Médical de Pneumologie, Polyclinique Saint Laurent
🇫🇷Rennes, France
Centre Hospitalier Universitaire de Tours - Hôpital Bretonneau
🇫🇷Tours, France
Centre Hospitalier Universitaire de Toulouse - Hôpital Larrey
🇫🇷Toulouse, France
Pierre-Henri GUILLAUD, MD
🇫🇷Vienne, France